Author

E. Sinakos

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis (MASLD/MASH) and Cardiovascular Risk: Emerging Therapeutic Strategies at the Interface of Liver and Cardiometabolic Disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are increasingly recognized as systemic cardiometabolic disorders rather than isolated liver diseases. Cardiovascular disease (CVD) represents the leading cause of mortalit...

C. Boutari, K. Charalampidis, L. Sideras et al. · Life · 0 citations

Review Open access Sep 2026

Immunotherapy for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Current Evidence and Challenges

Background/Objectives: Hepatocellular carcinoma (HCC) frequently develops in the set-ting of chronic liver disease, and liver transplantation (LT) represents the most effective curative option for selected patients. Despite advances in patient selection and surveillance, HCC recurrence after LT remains a major cause of...

S. Vasileiadou, S. Neiros, F. Karageorgos et al. · Transplantology · 0 citations

Open access Jul 2026

Clinical associations, outcomes, and therapeutic management of patients with symptomatic sclerosing mesenteritis

Background Sclerosing mesenteritis (SM) is a rare fibroinflammatory disease of unknown etiology that primarily affects the root of the small bowel mesentery. Associated diseases that contribute to or predispose to the development of SM have not been well-documented. Objectives We aimed to describe the clinical associat...

C. Liava, Danai Chourmouzi, Georgia Gioula et al. · Therapeutic Advances in Gast... · 0 citations